Moreover, we found that patients with papilledema who were refractory to steroids and immunosuppressants had good responses to TNFα inhibitors (because IL-1 inhibitors are not available in China), and these improvements were usually accompanied by decrease of intracranial pressure, yet optic atrophy presented in some of them was irreversible. This evidence concerns the gene IL1B and optic atrophy.